What is the difference between Significant Risk studies (SR) and Non-significant Risk studies (NSR)?
Topics: Signficant Risk, Non-Signficant Risk

What is the difference between Significant Risk studies (SR) and Non-significant Risk studies (NSR)?
Topics: Signficant Risk, Non-Signficant Risk
Dr. Harvey Arbit of Arbit Consulting has penned a whitepaper for IMARC Research titled, “Significant Risk/Non-Significant Risk Determination and IDE Applicability.” Although the Medical Device Amendments were enacted on May 28, 1976, it still seems that after all these years there is confusion and misunderstanding regarding the process for determining if an investigational device is Significant Risk (SR) or Non-Significant Risk (NSR).
Topics: Dr. Harvey Arbit, Signficant Risk, Non-Signficant Risk, FDA
Dr. Harvey Arbit of Arbit Consulting has penned a whitepaper for IMARC Research titled, “Significant Risk/Non-Significant Risk Determination and IDE Applicability.” Although the Medical Device Amendments were enacted on May 28, 1976, it still seems that after all these years there is confusion and misunderstanding regarding the process for determining if an investigational device is Significant Risk (SR) or Non-Significant Risk (NSR).
Topics: Dr. Harvey Arbit, Signficant Risk, Non-Signficant Risk, IMARC Research Whitepaper


This whitepaper examines the similarities and differences between various US and international regulations and place them within the context of any number of roles found within the realm of clinical research.